# Clarithromycin Mechanisms in Hypersomnia Syndromes

> **NCT04026958** · PHASE2 · COMPLETED · sponsor: **Emory University** · enrollment: 83 (actual)

## Conditions studied

- Narcolepsy Without Cataplexy
- Idiopathic Hypersomnia
- Narcolepsy With Cataplexy

## Interventions

- **DRUG:** Clarithromycin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04026958
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-04
- **Primary completion:** 2025-06-18
- **Final completion:** 2025-06-18
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2025-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04026958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04026958, "Clarithromycin Mechanisms in Hypersomnia Syndromes". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04026958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*